CLINICAL_TRIALS trial_result · 2021-10-13

Clinical Trial Update: Long-term Safety and Efficacy Study of Teduglutide in Pediatric Participants With Short Bowel Syndrome (SBS) [Phase 3]

A Phase 3 long-term safety and efficacy study of teduglutide in pediatric Short Bowel Syndrome completed, with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Shire | Conditions: Short Bowel Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2021-10-13